Kissei Pharmaceutical Co Ltd TSE:4547:

  • KISSEI PHARMACEUTICAL CO LTD: ANNOUNCEMENT FOR OPNION BY EUROPEAN AUTHORITIES ON TAVNEOS

  • KISSEI PHARMACEUTICAL CO LTD: ON JUNE 26, THE CHMP RECOMMENDED REVOKING THE MARKETING AUTHORIZATION IN THE EUROPEAN UNION FOR TAVNEOS, STATING THAT IT HAD NOT BEEN DEMONSTRATED THAT THE BENEFITS OUTWEIGH THE RISKS

  • KISSEI PHARMACEUTICAL CO LTD: THE CHMP'S OPINION HAS BEEN SUBMITTED TO THE EUROPEAN COMMISSION (EC), AND A FINAL DECISION BY THE EC IS EXPECTED LATER

  • KISSEI PHARMACEUTICAL CO LTD: KISSEI WILL CONTINUE THE DISCUSSIONS REGARDING THE APPROPRIATE MEASURES IN JAPAN WITH THE MINISTRY OF HEALTH, LABOUR AND WELFARE AND THE PHARMACEUTICALS AND MEDICAL DEVICES AGENCY

  • KISSEI PHARMACEUTICAL CO LTD: THE IMPACT OF THIS MATTER ON KISSEI’S BUSINESS PERFORMANCE IS CURRENTLY UNDER REVIEW